Review
Copyright ©The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Methodol. Mar 26, 2016; 6(1): 77-86
Published online Mar 26, 2016. doi: 10.5662/wjm.v6.i1.77
Updated overview of current biomarkers in head and neck carcinoma
Kiran Dahiya, Rakesh Dhankhar
Kiran Dahiya, Department of Biochemistry, Pt. B.D.Sharma PGIMS, Rohtak 124001, Haryana, India
Rakesh Dhankhar, Department of Radiotherapy, Pt. B.D.Sharma PGIMS, Rohtak 124001, Haryana, India
Author contributions: Dahiya K and Dhankhar R contributed to this article.
Conflict-of-interest statement: Authors declare no conflict of interests for this article.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Dr. Kiran Dahiya, Department of Biochemistry, Pt. B.D.Sharma PGIMS, 778/28, Bharat Colony, Rohtak 124001, Haryana, India. kirandahiya_2002@yahoo.com
Telephone: +91-98-96111985
Received: September 9, 2015
Peer-review started: September 9, 2015
First decision: November 7, 2015
Revised: January 20, 2016
Accepted: March 7, 2016
Article in press: March 9, 2016
Published online: March 26, 2016
Processing time: 191 Days and 11.7 Hours
Core Tip

Core tip: Early detection of head and neck squamous cell carcinoma is vital in improving the overall survival and prognosis. It can be achieved by use of latest biomarkers. With advancement in knowledge of molecular characteristics of this disease, various biomarkers acting at molecular level have been identified. This review compiles information regarding the potential players in this field.